Experts worried about exceptions process handling under DSCSA
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyComplianceNorth AmericaPharmaceuticalsProduct LifecycleQuality Assurance and ControlRegulatory Intelligence/Policy